Detailed Result for NCT00002398
NCT ID: | NCT00002398 |
---|---|
NLM Download Date Description: | N/A |
Study First Submitted Date: | 1999-11-02 |
Last Update Submitted Date: | 2005-06-23 |
Last Update Submitted Date: | 2005-06-23 |
Result First Submitted Date: | N/A |
Disposition First Submitted Date: | N/A |
Start Month Year: | N/A |
Start Date: | N/A |
Start Date Type: | N/A |
Verification Month Year: | December 1999 |
Verification Date: | 1999-12-31 |
Completion Month Year: | N/A |
Completion Date: | N/A |
Completion Date Type: | N/A |
Primary Completion Month Year: | N/A |
Primary Completion Date: | N/A |
Primary Completion Date Type: | N/A |
Study first Submitted QC Date: | 2001-08-30 |
Study first posted Date: | 2001-08-31 |
Result first Submitted QC Date: | N/A |
Result First Posted Date: | N/A |
Disposition First Submitted QC Date: | N/A |
Disposition First Posted Date: | N/A |
Last Updated Submitted QC Date: | 2005-06-23 |
Last Updated Posted Date: | 2005-06-24 |
Target Duration: | N/A |
Study Type: | Interventional |
Acronym: | N/A |
Baseline Population: | N/A |
Brief Title: | Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations |
Official Title: | A Randomized, Open-Label Expanded Access Program to Evaluate the Safety of Preveon (Adefovir Dipivoxil) at Two Dose Levels When Used in Combination With Other Antiretroviral Agents for the Treatment of Patients With HIV Infection Who Have Failed Other Antiretroviral Therapy and Have Limited Treatment Options |
Overall Status: | Completed |
Last Known Status: | N/A |
Phase: | Not Applicable |
Enrollment: | N/A |
Enrollment Type: | N/A |
Source: | NIH AIDS Clinical Trials Information Service |
Limitation and Caveats: | N/A |
Number of Arms: | N/A |
Number of Groups: | N/A |
Why Stopped: | N/A |
Has Expanded Access: | N/A |
Expanded Access Type Individual: | N/A |
Expanded Access Type Intermediate: | N/A |
Expanded Access Type Treatment: | N/A |
Has DMC: | N/A |
Is it FDA Regulated Drug: | N/A |
Is it FDA Regulated Device: | N/A |
Is it Unapproved Device: | N/A |
Is PPSD: | N/A |
Is US Export: | N/A |
Is Biospec Retention: | N/A |
Biospec Description: | N/A |
Plan to Share IPD: | N/A |
Plan to Share IPD Description: | N/A |
IPD Time Frame: | N/A |
IPD Access Criteria: | N/A |
IPD URL: | N/A |